Back

Value-based cardiovascular care in Ukraine: transitioning from generic monotherapy to branded fixed-dose combinations (FDCs) and pharmaceutical support

29 August 2026 (11:15 - 11:40)
Organised by: Logo
Congress Presentation Part of: Emerging perspectives in cardiovascular care: prevention, policy, and practice Health Economics ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Natalia Bilousova

Shupyk National Healthcare University of Ukraine, Kiev (Ukraine)

3 More presentations in this session

Presentation thumbnail
Cardiovascular disease prevention policy in the four nations of the United Kingdom: a policy document analysis from 2000-2025
Doctor I. Lyell (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Serious adverse events, hospitalization, and mortality associated with icosapent ethyl: a pharmacovigilance analysis using the FDA adverse event reporting system
Mr A. Draghici (Cluj-Napoca, RO)
Abstract Slides Video
Presentation thumbnail
Economic evaluation of Impella versus VA-ECMO in acute myocardial infarction cardiogenic shock
Doctor R. Batchelor (Melbourne, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Emerging perspectives in cardiovascular care: prevention, policy, and practice

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Fixed-dose combination drugs in hypertension
30 August 2025
thumbnail
Congress Presentation
Healthcare resource utilization (HCRU) and disease burden of hypertrophic cardiomyopathy: a nationwide population-based study from Sweden
30 August 2026
thumbnail
Congress Presentation
Impact of health insurance on long-term mortality after percutaneous coronary intervention in acute coronary syndrome patients: a nationwide propensity-weighted analysis
30 August 2026
thumbnail
Congress Presentation
Ten-year drug consumption for rare cardiovascular diseases in 66 countries and regions: a multinational drug utilization analysis
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources